Authors:
BENDING M
MELLOTTE G
HASHMI C
COLES GA
MORGAN JD
ASHMAN R
SCHURGERS ML
GORDIS BZ
DHOORE MM
FALLER B
GENESTIER S
GRAWEY I
SLINGENEYER A
LAROCHE B
VILLE JL
WINNEY RJ
PLANT WD
MILES RS
SCOUSE P
WILLIAMS P
MONCRIEFF N
BROWN C
NORMAN P
NICHOLS N
RENNES JG
HOLMES CJ
HUDSON I
HORTON D
Citation: M. Bending et al., NASAL MUPIROCIN PREVENTS STAPHYLOCOCCUS-AUREUS EXIT-SITE INFECTION DURING PERITONEAL-DIALYSIS, Journal of the American Society of Nephrology, 7(11), 1996, pp. 2403-2408
Authors:
BOELAERT JR
VANLANDUYT HW
DEBAERE YA
DERUYTER MM
DANEELS RF
SCHURGERS ML
MATTHYS EG
GORDTS BZ
Citation: Jr. Boelaert et al., STAPHYLOCOCCUS-AUREUS INFECTIONS IN HEMODIALYSIS-PATIENTS - PATHOPHYSIOLOGY AND USE OF NASAL MUPIROCIN FOR PREVENTION, Journal of chemotherapy, 7, 1995, pp. 49-53
Authors:
DHAESE PC
SHAHEEN FA
HURAIB SO
DJUKANOVIC L
POLENAKOVIC MH
SPASOVSKI G
SHIKOLE A
SCHURGERS ML
DANEELS RF
LAMBERTS LV
VANLANDEGHEM GF
DEBROE ME
Citation: Pc. Dhaese et al., INCREASED SILICON LEVELS IN DIALYSIS PATIENTS DUE TO HIGH-SILICON CONTENT IN THE DRINKING-WATER, INADEQUATE WATER-TREATMENT PROCEDURES, ANDCONCENTRATE CONTAMINATION - A MULTICENTER STUDY, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1838-1844